Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Staging and Prognosis Model of Bladder Cancer Based on Artificial Intelligence and Multimodal Omics Features

NCT06565923 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT06565923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Staging and Prognosis Model of Bladder Cancer Based on Artificial Intelligence and Multimodal Omics Features
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
March 18, 2024
Completion date
July 18, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer